<--- Back to Details
First PageDocument Content
Health / Immunosuppressants / Arthritis / Pharmacology / Rheumatoid arthritis / Anakinra / Disease-modifying antirheumatic drug / Pharmaceutical drug / Ankylosing spondylitis / Autoimmune diseases / Medicine / Chemistry
Date: 2014-11-27 00:18:46
Health
Immunosuppressants
Arthritis
Pharmacology
Rheumatoid arthritis
Anakinra
Disease-modifying antirheumatic drug
Pharmaceutical drug
Ankylosing spondylitis
Autoimmune diseases
Medicine
Chemistry

Microsoft Word - Document in Windows Internet Explorer

Add to Reading List

Source URL: chfs.ky.gov

Download Document from Source Website

File Size: 86,30 KB

Share Document on Facebook

Similar Documents

Medicine / Clinical medicine / Immunology / RTT / Autoimmune diseases / Immunosuppressants / Rheumatology / Arthritis / Disease-modifying antirheumatic drug / Infliximab / Methotrexate / Psoriatic arthritis

Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8Toll Free on PEI) Programmes provinciaux de médicaments

DocID: 1qAvE - View Document

Medicine / Clinical medicine / Immunology / Immunosuppressants / Monoclonal antibodies / Biotechnology / Immune system / TNF inhibitor / Infliximab / Adalimumab / Disease-modifying antirheumatic drug / Etanercept

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qius - View Document

Medicine / Clinical medicine / Immunology / Immunosuppressants / RTT / Autoimmune diseases / Monoclonal antibodies / Arthritis / Disease-modifying antirheumatic drug / Psoriatic arthritis / Infliximab / Rheumatoid arthritis

THE EFFECTIVENESS OF NON BIOLOGIC DMARDS AFTER ANTI TNF α INHIBITOR FAILURE DECISION SUPPORT UNIT Allan Wailoo, Jonathan Tosh School of Health and Related Research, University of Sheffield

DocID: 1pY4l - View Document

Monoclonal antibodies / Autoimmune diseases / Biotechnology / Immunosuppressants / Immunology / TNF inhibitor / Rheumatology / Adalimumab / Infliximab / Arthritis / Disease-modifying antirheumatic drug / Rheumatoid arthritis

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1pESm - View Document

Health economics / Healthcare quality / Immunosuppressants / Orphan drugs / Costs / Disease-modifying antirheumatic drug / Tocilizumab / Rituximab / Quality-adjusted life year / Rheumatoid arthritis / Etanercept / TNF inhibitor

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

DocID: 1pnYX - View Document